Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus.

Soria-Juan B, Escacena N, Capilla-González V, Aguilera Y, Llanos L, Tejedo JR, Bedoya FJ, Juan V, De la Cuesta A, Ruiz-Salmerón R, Andreu E, Grochowicz L, Prósper F, Sánchez-Guijo F, Lozano FS, Miralles M, Del Río-Solá L, Castellanos G, Moraleda JM, Sackstein R, García-Arranz M, García-Olmo D, Martín F, Hmadcha A, Soria B; Collaborative Working Group “Noma Project Team”.

Front Immunol. 2019 Jun 4;10:1151. doi: 10.3389/fimmu.2019.01151. eCollection 2019.

2.

Zn2+ chelation by serum albumin improves hexameric Zn2+-insulin dissociation into monomers after exocytosis.

Pertusa JAG, León-Quinto T, Berná G, Tejedo JR, Hmadcha A, Bedoya FJ, Martín F, Soria B.

PLoS One. 2017 Nov 3;12(11):e0187547. doi: 10.1371/journal.pone.0187547. eCollection 2017.

3.

Regulation of mitochondrial function and endoplasmic reticulum stress by nitric oxide in pluripotent stem cells.

Caballano-Infantes E, Terron-Bautista J, Beltrán-Povea A, Cahuana GM, Soria B, Nabil H, Bedoya FJ, Tejedo JR.

World J Stem Cells. 2017 Feb 26;9(2):26-36. doi: 10.4252/wjsc.v9.i2.26. Review.

4.

Differentiation of Mouse Embryonic Stem Cells toward Functional Pancreatic β-Cell Surrogates through Epigenetic Regulation of Pdx1 by Nitric Oxide.

Salguero-Aranda C, Tapia-Limonchi R, Cahuana GM, Hitos AB, Diaz I, Hmadcha A, Fraga M, Martín F, Soria B, Tejedo JR, Bedoya FJ.

Cell Transplant. 2016 Oct;25(10):1879-1892. doi: 10.3727/096368916X691178.

PMID:
26980118
5.

Nitric Oxide Prevents Mouse Embryonic Stem Cell Differentiation Through Regulation of Gene Expression, Cell Signaling, and Control of Cell Proliferation.

Tapia-Limonchi R, Cahuana GM, Caballano-Infantes E, Salguero-Aranda C, Beltran-Povea A, Hitos AB, Hmadcha A, Martin F, Soria B, Bedoya FJ, Tejedo JR.

J Cell Biochem. 2016 Sep;117(9):2078-88. doi: 10.1002/jcb.25513. Epub 2016 Mar 8.

PMID:
26853909
6.

Using stem cells to produce insulin.

Soria B, Gauthier BR, Martín F, Tejedo JR, Bedoya FJ, Rojas A, Hmadcha A.

Expert Opin Biol Ther. 2015;15(10):1469-89. doi: 10.1517/14712598.2015.1066330. Epub 2015 Jul 9. Review.

7.

Role of nitric oxide in the maintenance of pluripotency and regulation of the hypoxia response in stem cells.

Beltran-Povea A, Caballano-Infantes E, Salguero-Aranda C, Martín F, Soria B, Bedoya FJ, Tejedo JR, Cahuana GM.

World J Stem Cells. 2015 Apr 26;7(3):605-17. doi: 10.4252/wjsc.v7.i3.605. Review.

8.

Impact of exposure to low concentrations of nitric oxide on protein profile in murine and human pancreatic islet cells.

Tapia-Limonchi R, Díaz I, Cahuana GM, Bautista M, Martín F, Soria B, Tejedo JR, Bedoya FJ.

Islets. 2014;6(5-6):e995997. doi: 10.1080/19382014.2014.995997.

9.

Transient Downregulation of Nanog and Oct4 Induced by DETA/NO Exposure in Mouse Embryonic Stem Cells Leads to Mesodermal/Endodermal Lineage Differentiation.

Mora-Castilla S, Tejedo JR, Tapia-Limonchi R, Díaz I, Hitos AB, Cahuana GM, Hmadcha A, Martín F, Soria B, Bedoya FJ.

Stem Cells Int. 2014;2014:379678. doi: 10.1155/2014/379678. Epub 2014 Dec 3.

10.

Nutrigenetics and nutrigenomics insights into diabetes etiopathogenesis.

Berná G, Oliveras-López MJ, Jurado-Ruíz E, Tejedo J, Bedoya F, Soria B, Martín F.

Nutrients. 2014 Nov 21;6(11):5338-69. doi: 10.3390/nu6115338. Review.

11.

Regulation of pancreatic β-cell survival by nitric oxide: clinical relevance.

Bedoya FJ, Salguero-Aranda C, Cahuana GM, Tapia-Limonchi R, Soria B, Tejedo JR.

Islets. 2012 Mar-Apr;4(2):108-18. doi: 10.4161/isl.19822. Epub 2012 Mar 1. Review.

PMID:
22614339
12.

Monoclonal antibody that recognizes a domain on heterogeneous nuclear ribonucleoprotein K and PTB-associated splicing factor.

Garcia-Jurado G, Llanes D, Moreno A, Soria B, Tejedo JR.

Hybridoma (Larchmt). 2011 Feb;30(1):53-9. doi: 10.1089/hyb.2010.0081.

PMID:
21466286
13.

Islet cell development.

Rojas A, Khoo A, Tejedo JR, Bedoya FJ, Soria B, Martín F.

Adv Exp Med Biol. 2010;654:59-75. doi: 10.1007/978-90-481-3271-3_4. Review.

PMID:
20217494
14.

Nitric oxide mediates the survival action of IGF-1 and insulin in pancreatic beta cells.

Cahuana GM, Tejedo JR, Hmadcha A, Ramírez R, Cuesta AL, Soria B, Martin F, Bedoya FJ.

Cell Signal. 2008 Feb;20(2):301-10. Epub 2007 Oct 12.

PMID:
18023142
15.

Homocysteine enhances superoxide anion release and NADPH oxidase assembly by human neutrophils. Effects on MAPK activation and neutrophil migration.

Alvarez-Maqueda M, El Bekay R, Monteseirín J, Alba G, Chacón P, Vega A, Santa María C, Tejedo JR, Martín-Nieto J, Bedoya FJ, Pintado E, Sobrino F.

Atherosclerosis. 2004 Feb;172(2):229-38.

PMID:
15019532
16.

nitric oxide triggers the phosphatidylinositol 3-kinase/Akt survival pathway in insulin-producing RINm5F cells by arousing Src to activate insulin receptor substrate-1.

Tejedo JR, Cahuana GM, Ramírez R, Esbert M, Jiménez J, Sobrino F, Bedoya FJ.

Endocrinology. 2004 May;145(5):2319-27. Epub 2004 Feb 5.

PMID:
14764634
17.

Nitric oxide-induced carbonylation of Bcl-2, GAPDH and ANT precedes apoptotic events in insulin-secreting RINm5F cells.

Cahuana GM, Tejedo JR, Jiménez J, Ramírez R, Sobrino F, Bedoya FJ.

Exp Cell Res. 2004 Feb 1;293(1):22-30.

PMID:
14729054
18.

Involvement of advanced lipooxidation end products (ALEs) and protein oxidation in the apoptotic actions of nitric oxide in insulin secreting RINm5F cells.

Cahuana GM, Tejedo JR, Jiménez J, Ramírez R, Sobrino F, Bedoya FJ.

Biochem Pharmacol. 2003 Nov 15;66(10):1963-71.

PMID:
14599554

Supplemental Content

Loading ...
Support Center